Coastal Infusion Administers Remicade^®

Remicade (infliximab-dyyb) is used to treat rheumatoid arthritis (RA) and psoriatic arthritis, Crohn's disease, and ulcerative colitis (UC). Remicade also treats plaque psoriasis and ankylosing spondylitis.

Remicade primarily works by inhibiting the action of TNF-alpha, a cytokine involved in the inflammatory response. By blocking TNF-alpha, Remicade helps modulate the overactive immune response seen in these diseases.

By reducing inflammation, Remicade helps alleviate symptoms associated with autoimmune diseases and bowel diseases, such as joint pain, swelling, inflammation, immobility, and overall disease management.

What It Treats

• Crohn's disease
• Ulcerative colitis (UC)
• Rheumatoid arthritis (RA)
• Psoriatic arthritis
• Plaque psoriasis
• Ankylosing spondylitis

Prescribed By

Remicade is most often prescribed by Gastroenterologists, Rheumatologists, and Dermatologists.

How it's Administered

Remicade is administered by intravenous infusion. Remicade infusions take about two hours.

Frequency

Remicade is administered every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks.

Related Drugs

Avsola, Inflectra, Renflexis

Additional Resources

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies